iPledge, an even stricter risk management program for isotretinoin (Accutane, etc)

September 2005

You'll soon hear about iPledge, an even stricter risk management program for isotretinoin (Accutane, etc).

It'll be similar to the STEPS program for thalidomide.

Too many women are still getting isotretinoin without the required pregnancy tests.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

marketing wars over the new sleeping pills
Women's Health Ortho Evra contraceptive patch and reports of deaths due to blood clots
Women's Health which drugs decrease efficacy of oral contraceptives (OCs)
Infectious Diseases CDC just released new guidelines for the 2005-2006 flu season
Diabetes two new investigational drugs for diabetes
a new inhaled corticosteroid called Asmanex
appropriate use of long-acting inhaled beta-agonists for asthma
alternatives to pseudoephedrine
Cholesterol There's confusion about all the different formulations of fenofibrate
Supplements how ginkgo interacts with other drugs
Supplements A new study is raising the question of whether echinacea is useful for the common cold
Dermatology iPledge, an even stricter risk management program for isotretinoin (Accutane, etc)
Pediatrics whether autism is caused by thimerosal in vaccines
Patient Privacy/HIPAA what HIPAA allows when discussing drug therapy
Practice higher risk of hypertension in women taking chronic NSAIDs or acetaminophen